LUPIN Earnings Summary – Lupin Limited Reports 26.4% Revenue Growth in Third Quarter FY2026 6 hours ago Lupin Limited (NSE: LUPIN) is a global pharmaceutical company specializing in branded and generic formulations, biotechnology, and active pharmaceutical ingredients.…